Better Buy: Gilead Sciences Inc. vs. Johnson & Johnson

Which of these two healthcare giants is the better pick for investors?

They're two of the biggies in healthcare. Gilead Sciences Inc. (NASDAQ:GILD) grew to become the largest biotech in the world over the last decade on the back of its HIV and hepatitis C franchises. Meanwhile, Johnson & Johnson (NYSE:JNJ) has remained the biggest healthcare company overall for years with its consumer products, medical device, and prescription drug segments.

The companies both cooperate with and compete against each other. Gilead and J&J teamed up to develop HIV drugs Complera and Eviplera. In the hepatitis C market, though, Gilead's Sovaldi and Harvoni clobbered J&J's Olysio.

Which of these two giants is the better pick for investors right now?...

Forget Rising Rates. 5 Great REITs To Buy Today

Some REITs have what it takes to outperform in this sort of environment Real estate investment trusts (REITs) have really take...